CURIS, INC. Share-based Payment Arrangement, Expense, Tax Benefit
CURIS, INC. (CRIS) reported Share-based Payment Arrangement, Expense, Tax Benefit of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-03-24
- CURIS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $0.00.
- CURIS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $0.00.
- CURIS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $0.00.
- CURIS, INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $0.00.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-19 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-26 |
| 2014-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2012-12-31 | $0.00 10-K · filed 2015-02-24 |
| 2011-12-31 | $0.00 10-K · filed 2014-03-13 |
| 2010-12-31 | $0.00 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |